Bendong, Avelino L.

HRN: 24-43-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2025
CEFUROXIME 750MG (VIAL)
10/24/2025
10/31/2025
IV
750mg
Q8
Cholecystitis

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Non-compliant To Guidelines